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DYNAMICS OF MATERNAL AND INFANT VITAMIN E TOCOPHEROLS  
DURING NICU HOSPITALIZATION 
Jana K. Wells, RD, LMNT, CNSC 
University of Nebraska, 2017 
Advisor: Corrine K Hanson, PhD, RD, LMNT 
OBJECTIVE:  The main objective of this prospective cohort is to investigate serum levels of vitamin E 
tocopherol isoforms (specifically alpha and gamma) in mothers and infants admitted to the Neonatal 
Intensive Care Unit (NICU) in relation to infant feeding modality. 
METHODS:  This was a prospective cohort of 34 mothers and their infants admitted to the neonatal 
intensive care unit (NICU).  Samples of maternal and cord blood were collected at the time of delivery, 
and a food frequency questionnaire (FFQ) was administered to the mother to measure maternal vitamin E 
tocopherol intake.  After nutrition treatment of each feeding modality had been stable for 72 hours, blood 
samples were collected from participating infants during the administration.  Serum tocopherols were 
measured in the Biomarker Research laboratory at the Harvard School of Public Health using high-
performance liquid chromatography (HPLC).  Descriptive statistic and Spearman correlation coefficients 
were calculated.  P-value <0.05 was considered statistically significant. 
RESULTS:  The mean birth weight was 2738.0 ± 835.7 gm and mean gestational age was 36.7 ± 3.4 
weeks.  Vitamin E deficiency was present in 64.5% of infants and 41.9% of mothers.  No significant 
correlations were found between gestation age or birth weight and infant α- and γ-tocopherol levels or 
between maternal and infant serum α- and γ-tocopherol levels.  Additionally, no significant correlations 
were found between maternal serum or maternal intake and α- and γ-tocopherol levels in maternal breast 
milk samples.  No significant difference was found between groups when comparing α- and γ-tocopherol 
levels of infants after 3 days stable on a feeding modality. 
CONCLUSION:  There is a high prevalence of vitamin E deficiency in mothers and infants.  Further 
research is needed to identify how to safely raise levels to prevent complications of deficiency in infants.  
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CHAPTER 1: INTRODUCTION 
Vitamin E is a major chain-breaking antioxidant thought to function by preventing the 
propagation of lipid peroxidation.1  Vitamin E occurs naturally as eight different isoforms, including 
alpha and gamma tocopherol which differ by one methyl group (Figure 1).2  Isoforms are not 
interconvertible in humans and, as a result, increased intakes of alpha- or gamma-tocopherol in the diet 
will cause a rise in serum tissue concentrations of that specific tocopherol.3  In tissues, serum α-
tocopherol levels are approximately 10  
 
times higher than γ-tocopherol due to a preferential transfer of α-tocopherol to lipid particles by liver α-
tocopherol transfer protein (αTTP) and a higher rate of production of γ-tocopherol metabolites for 
excretion.4  Importantly, serum and tissue levels of vitamin E isoforms correlate, meaning dietary intake 
of tocopherols has the potential to influence biological mechanisms.5,6 
Vitamin E regulation of disease has been extensively studied in humans, animal models, and cell 
systems.  Clinical studies primarily focus on the α-tocopherol isoform without adjustment for the dietary 
contribution of γ-tocopherol to the outcome.  It has been recently reported that supplementation with 
physiological levels of purified natural forms of the Vitamin E isoforms α-tocopherol is anti-
inflammatory and γ-tocopherol is pro-inflammatory.4,6-8  The contradictory outcomes in vitamin E in 
research may be due, in part, to the different and possibly opposing inflammatory properties of isoforms. 
Figure 1: Structures of Alpha- and Gamma-Tocopherol Isoforms 
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Deficiency is not often seen in adults, but is more frequently found in children due to limited 
stores and rapid growth.9  Vitamin E is of critical importance in early infancy, as deficiency has 
devastating consequences such as hemolytic anemia, retrolental fibroplasia, intraventricular hemorrhage 
(IVH), bronchopulmonary dysplasia (BPD), and delays in the development of the central nervous 
system.10  Placental transfer of vitamin E to the fetus is limited and the expectant mother has little 
influence on the delivery of this substance to the fetus.11  Therefore, maintenance and repletion of vitamin 
E stores after birth through other inputs is required.  In clinical practice, there is a dependence on dietary 
intake to supply this crucial nutrient.12,136   
 Infant formula is designed to be an alternative food source similar to that of human milk for 
newborns.  However, infant formula is highly distinct from that of human milk as human milk contains 
high concentrations of α-tocopherol while γ-tocopherol is the dominant isoform in infant formula. The 
potentially distinct vitamin E profile between human milk and infant formula could be a contributing 
factor to the greater susceptibility of formula-fed infants to contract inflammatory conditions compared to 
breast-fed infants.14 
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CHAPTER 2: BACKGROUND & REVIEW OF LITERATURE 
OVERVIEW OF VITAMIN E 
Structure, Metabolism and Storage:   
The term Vitamin E refers to a group of eight lipid-soluble compounds: the α-, β-, γ-, and δ-
tocopherols and the α-, β-, γ-, and δ-tocotrienols.4  These different forms, often referred to as 
“tocochromanols or tocols,” vary in their biological availability and in their physiological and chemical 
activities.  As shown in figure 2, tocopherols and tocotrienols consist of a chromanol head group linked to 
an isoprenoid-derived hydrophobic tail.  The aliphatic tail of tocopherols is fully saturated, while the side-
Figure 2: Tocopherol and Tocotrienol Molecular Structures 
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chain of tocotrienols contains three, trans double bonds.  All of these molecules possess antioxidant 
activity, but α-tocopherol is thought to be chemically and biologically the most active.15  The other 
naturally occurring forms of vitamin E (β-, γ-, and δ- tocopherols and α-, β, γ, and δ-tocotrienols) do not 
contribute toward meeting the vitamin E requirement because, although absorbed, they are not converted 
to α-tocopherol by humans, and they are poorly recognized by α-TTP in the liver.16  The biological 
activity of vitamin E is normally expressed as international units relative to that of all-rac-α-tocopherol 
acetate, or the synthetic form.  The relative values in International Units (IU) per mg are 1.00 for all- rac-
α-tocopherol acetate, 1.36 for RRR-α-tocopherol acetate, 1.49 for RRR-β-tocopherol, 0.12-0.28 for RRR-γ-
tocopherol, and 0.01-0.04 for RRR-δ-tocopherol according to the resorption-gestation test.17   
Vitamin E was first recognized as a lipid-soluble substance necessary for the prevention of fetal 
death and resorption in rats that had been fed a rancid lard diet.18  It is a major chain-breaking antioxidant 
thought to function to prevent the propagation of lipid peroxidation.1  Tocopherols and tocotrienols play 
important roles in the oxidative stability of vegetable oils and in the nutritional quality of crop plants for 
human and livestock diets.2  Vitamin E is involved in immune function, cell signaling, regulation of gene 
expression, and other metabolic processes.19  In addition, it also increases the expression of two enzymes 
that suppress arachidonic acid metabolism, thereby increasing the release of prostacyclin from the 
endothelium, which dilates blood vessels and inhibits platelet aggregation.20   
The α- and γ-tocopherol isoforms are the most abundant isoforms in diet and tissues, with α-
tocopherol being the predominant form in mammalian plasma and the only form present in vitamin 
supplements.21,22  The main source for dietary uptake of vitamin E is vegetables, plants, and plant oils. 
Plants synthesize the natural isoforms, or RRR-tocopherol (formerly called d-alpha tocopherol), of 
vitamin E from tyrosine and chlorophyll and are consumed in the diet from plant lipids.2  In the United 
States diet, γ-Tocopherol is the principle vitamin E isoform consumed, being about 2.5 times as abundant 
in food as α-tocopherol.23  Main sources of γ-tocopherol include walnuts, pecans, peanuts, soybean oil, 
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corn oil, and cottonseed oil, while α-tocopherol is primarily found in olive, sunflower, and safflower oils 
in addition to sunflower seeds and almonds.24,25  Soybean oil is the predominant vegetable oil in the 
American diet (76.4%) followed by corn oil and canola oil (both 7%).26  The average plasma γ-tocopherol 
level in the United States and the Netherlands has been reported as approximately 2-6 times higher than 
that reported for 6 European countries including Italy that consume higher amounts of α-tocopherol rich 
foods.26  It is presumed that as countries assume western lifestyles, diets change including increased 
consumption of soybean oil with corresponding increases in plasma γ-tocopherol.27 
The Institute of Medicine (IOM) reported that the effect of 300 mg of supplemental vitamin E 
was to increase plasma α-tocopherol concentrations threefold and to at least double most tissue 
concentrations, while supplementation with 30 mg had little effect on either plasma or tissue α-tocopherol 
concentrations.20  Synthetic forms of α-tocopherol are found in fortified foods and vitamin supplements.  
Dietary supplements generally contain 100 IU to 1,000 IU α-tocopherol and contain only RRR-α-
tocopherol.  Large quantities of vitamin E have been shown to lead to multiple metabolic and cellular 
changes in humans. Effects of vitamin E supplementation include inhibition of low density lipoprotein 
(LDL) oxidation both in vitro and in vivo, inhibition of smooth muscle cell proliferation through 
Figure 3: Various forms of Vitamin E Isoforms in Edible Vegetable Oils20 
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inhibition of protein kinase Cα (PKCα), inhibition of platelet aggregation,28 and inhibition of plasma 
generation thrombin.16   
Vitamin E is dependent on biliary and pancreatic secretions and is taken up as the free alcohol 
form by the intestine without discrimination of the individual isomers.16  Prior to absorption, tocopherol 
esters are hydrolyzed in the intestine, making the bioavailability of free RRR-α-tocopherol and RRR-α-
tocopherol acetate very similar.29  After absorption, tocopherols are loaded in intestinal-formed 
chylomicrons which are then transported in the lymph to the liver where they are transferred to lipid 
particles.30  Here, the natural RRR-α-tocopherol form has the highest biopotency as the α-TTP has a 
higher affinity for the natural isoform and enables the selective (but not exclusive) transfer of α-
tocopherol across membranes and its incorporation into very low density lipoproteins (VLDLs).31,32  After 
absorption, vitamin E isomers other than α-tocopherols are readily converted to their respective CEHC 
metabolite forms, even during α-tocopherol deficiency.33  The secretory pathway via VLDL from the liver 
is critical in maintaining tocopherol concentrations in plasma, and discrimination among the isomers by 
α-TTP occurs during hepatic secretion of VLDL.34,35  Therefore, hepatic vitamin E metabolism is a major 
regulator of the forms of vitamin E found in the body and once liver α-tocopherol concentration reaches a 
threshold level, additional α-tocopherol will be metabolized and α- carboxyethylchromans (CEHC) 
excretion increases exponentially.33  However, some tocopherols in the VLDLs may end up in LDL by 
the action of lipoprotein lipase in plasma.32  Finally, the tocopherols secreted are either rapidly returned 
from blood to the liver or excreted to feces.  Based on recovery studies, 55-77% of radiolabeled α-
tocopherol were absorbed.36  By regulating the transfer and binding of tocopherols, α-TTP plays a key 
role in determining plasma concentrations and biological activities.   
Vitamin E is taken up by several tissues, including liver, lung, heart, skeletal muscle, and adipose 
tissue.37  In tissues, α-tocopherol is approximately 10 times higher than γ-tocopherol due to preferential 
transfer of α-tocopherol to lipid particles by liver α-TTP and a higher rate of production of γ-tocopherol 
metabolites (CEHC), for excretion.21,38  Burton et al.39 has reported that γ-tocopherol constitutes as much 
7 
 
as 30-50% of the total vitamin E in human skin, muscle, vein, and adipose tissue. However, although γ-
tocopherol concentrations in these tissues appear to be 20-40 fold greater than those in plasma, the isomer 
has only about one-tenth of the vitamin E activity of α-tocopherol.37 Plasma concentrations of vitamin E 
peak at 12-14 hours after administration:  13.5 hours for RRR-α-tocopherol, about 12 hours for RRR-α-
tocopherol acetate, and 12.6 hours for synthetic tocopherol acetate,40,41 while time to peak concentration 
of γ-tocopherol appear to be about 9 hours.35  In North America, Schweldhelm, et al.42 reported the serum 
concentrations of α- and γ-tocopherol are approximately 20.5 + 6.6 µmol/L and 3.1 µmol/L respectively.  
Figure 4: Vitamin E secretion in Chylomicrons and Distribution to Circulating 
Lipoproteins20 
 
The antioxidant activity of tocopherols is rooted in their ability to donate electrons to lipid 
radicals.25  Because of its lack of the electron-donating methyl groups on the chromanol ring, γ-tocopherol 
is somewhat less potent in donating electrons than is α-tocopherol, and is therefore thought to be a less 
powerful antioxidant.43  Both α-tocopherol and γ-tocopherol have a similar ability to scavenge reactive 
oxygen species (ROS).44  Excess generation of ROS may promote inflammation with increases in reactive 
nitrogen species and is associated with chronic inflammation-related diseases such as cancer, cardio-
vascular disease (CVD), and neurodegenerative disorders.45-48   
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Cook-Mills et al. proposed that α- and γ-tocopherols have opposing regulatory effects on 
leukocyte recruitment and vascular cell adhesion molecule-1 (VCAM-1).4,30  Leukocytes bind to these 
adhesion molecules and then the bound leukocytes are recruited into tissues by 
chemokines/chemoattractants.49  VCAM-1 signals through low levels of ROS which are regulated by 
tocopherols.6,50-52  During inflammation, VCAM-1 expression is induced on endothelial cells30 and during 
allergic inflammation in the lung, eosinophil migration is dependent on VCAM-1.50  VCAM-1 activates 
NADPH oxidase (NOX2) that generates ROS for the activation of PKCα, a serine/threonine kinase that 
utilizes the cofactors PS (phosphatidylserine), DAG (diacylglycerol) and calcium for activation.53  
McCary et al.5 reported tocopherols directly bind and regulate PKCα.  While α-tocopherol decreases 
activation, γ-tocopherol enhances activation of recombinant PKCα.  Therefore, α-tocopherol is an 
antagonist and γ-tocopherol is an agonist of PS-dependent PKCα activity.  In the same paper, both α- and 
γ-tocopherol inhibited the oxidative activation of recumbent PKCα, suggesting both tocopherols possess 
an antioxidant effect.  However, α-tocopherol significantly decreased hydrogen peroxide activation of 
PKCα at a 10-fold lower dose compared with γ-tocopherol.  McCary, et al. concluded α-tocopherol may 
inhibit VCAM-1 signaling by functioning both as an antioxidant and as an antagonist of PKCα while γ-
tocopherol elevates VCAM-1 activation of PKCα and ablates the inhibitory effects of α-tocopherol on 
VCAM-1 activation of PKCα in endothelial cells.   
In 2009, Berdnikovs, et al.6 studied the effect of α-tocopherol and γ-tocopherol alone or in 
combination on eosinophilic lung inflammation and airway hyperresponsiveness in female mice.  In vitro, 
α-tocopherol decreased whereas natural γ-tocopherol elevated VCAM-1-dependent lymphocyte 
transmigration at physiological concentrations by a direct regulatory function in endothelial cells.  α-
tocopherol decreased and γ-tocopherol increased endothelial cell signaling during leucocyte migration 
across endothelial cells in vitro.54  Additionally, when γ-tocopherol and α-tocopherol were given 
simultaneously, γ-tocopherol blocked the inhibition of the leukocyte transendothelial migration.  
Additionally, These findings were reflected in the recent results of retrospective cohorts that have found 
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statistically significant inverse relationships between γ-tocopherol and FEV1 and FVC whereas higher α-
tocopherol was associated with higher FVC.22,55  Alternatively, a multi-center RCT in the United States 
showed long-term supplementation with vitamin E (400 IU/day all rac-α-tocopherol acetate) had no 
effect on FEV1.56  
Yang, et al.57 showed that serum γ-tocopherol was associated with increasing concentrations of 
inflammatory biomarkers, including high-sensitivity C-reactive protein (HS-CRP), serum amyloid A 
(SAA), and E-selectin (Ptrend all < 0.0001), while α-tocopherol was associated with decreasing 
concentrations of IL-6 and hs-CRP (Ptrend all < 0.001).  Elisia et al.58 researched the relative abilities of 
different tocopherol isoforms to modulate intestinal oxidative stress and inflammatory responses and 
found tocopherol isoform promotion of Interleukin 8 (IL8) production was isoform specific in the fetal-
derived FHs 74 Int intestinal cell line challenged with interferon-gamma/phorbol myristate acetate 
(IFNγ/PMA).  After treatment of cells with 100 µM tocopherol isoforms (α- and γ-tocopherol), γ-
tocopherol produced a significant (P < 0.05) increase in IL8 (eightfold).  That level was also higher than 
that induced by α-tocopherol (twofold increase) as compared to control cells that were incubated with 
IFNγ/PMA alone.59  Results showed that γ-tocopherol can modulate a greater inflammatory response than 
α-tocopherol. 
Studies exploring vitamin E on asthma have also focused on the opposing effects of α- and γ-
tocopherol isoforms.  Cook-Mills, et al.60 found the relationship of α-tocopherol on asthma risk varied 
with γ-tocopherol tertile.  In the highest γ-tocopherol tertile, low levels of α-tocopherol appear to be 
associated with a marked elevation in asthma risk, while the highest tertile α-tocopherol levels tended to 
be protective.  Abdala-Valencia, et al.7,8 studied the effect of α- and γ-tocopherol supplementation in 
allergic female mice, with opposing results reported.  Allergic, female mice receiving γ-tocopherol 
supplementation had pups with twofold the number of eosinophils in the bronchoalveolar lavage and 
lungs after allergen challenge,8 while mice supplemented with α-tocopherol7 had pups with reduced 
allergen-induced lung mRNA expression of IL-4, IL-33, TSLP, CCL11, and CCL24.   
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It has been suggested that vitamin E tocopherols can reduce the risk of cancer due to their strong 
antioxidant properties.61,62  Multiple recent studies have shown dietary vitamin E intake is inversely 
associated with cancer risk.63-73  However, supplemental vitamin E continues to be debated due to 
previous studies such as the Selenium and Vitamin E Cancer Prevention Trial (SELECT)74 and the Alpha-
Tocopherol and Beta-Carotene (ATBC) trial,75  which suggested vitamin E supplementation increased the 
risk of prostate cancer and renal-cell carcinoma, respectively.  In the past, the relationship between dietary 
intake of tocopherols and lung cancer risk has been evaluated in several prospective studies, with the 
majority showing no significant association.76-81  However, in a cohort of tin miners in China, 
Ratansinghe et al.82 found a significant gradient of decreasing lung cancer risk in men less than 60 years 
old with increasing serum α-tocopherol levels (OR by tertile: 1.0, 0.9, 0.2; P for trend = 0.002). In another 
study, point estimates comparing 4th quartile to 1st quartile of males, Goodman et al.83 found serum 
concentration of α-tocopherol were significantly inversely associated with ORs of lung cancer (OR, 95% 
CI; 0.49, 0.25-0.95).  Wu, et al.68 prospectively investigated the associations between tocopherol intake 
from diet and supplements with lung cancer risk among 77,829 Chinese, female, nonsmokers aged 40-70 
years participating in the Shanghai Women’s Health Study.  Total dietary tocopherol was inversely 
associated with lung cancer risk among women meeting dietary guidelines for adequate intake of 
tocopherol (14 mg/day or more: HR: 0.78; 95% CI 0.60-0.99; compared with the category less than 
adequate intake).  In contrast, vitamin E supplement use was associated with increased lung cancer risk 
(HR: 1.33; 95% CI: 1.01-1.73), more so for lung adenocarcinoma risk (HR: 1.79; 95% CI: 1.23-2.60).  
Sayin, et al.84 studied the impact of antioxidant supplementation (DL-α-tocopheryl acetate at doses of 
12.5 and 61.5 mg/kg body weight) on tumor progression, severity, and lethality in mouse models of 
endogenous lung cancer in a RCT.  Vitamin E supplementation reduced ROS and DNA damage, 
prevented p53 activation, and markedly increased tumor cell proliferation and tumor growth in mice, 
suggesting tumor cells proliferate faster when oxidative stress is suppressed.  The impact of vitamin E on 
tumor initiation or prevention was not analyzed by Sayin, et al. and only used vitamin E in the 
supplemental form was used to obtain results.  A meta-analysis by Chen, et al.85 summarized the evidence 
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from epidemiological studies of vitamin E intake with the risk of lung cancer and concluded high intake 
of vitamin E might have a protective effect against lung cancer.  The combined relative risk of lung 
cancer associated with vitamin E intake was 0.858 (95% CI = 0.742-0.991).  Significant protective 
associations were also found in American population (RR = 0.862, 95% CI: 0.715-0.996) and prospective 
studies (RR = 0.913, 95% CI=0.827-0.996).   
Dietary Reference Intakes:   
The determination of how much of a nutrient is required daily is dependent on specifically 
assessing a nutrient’s function and also by defining a biomarker that is indicative of inadequacy that 
changes with nutrient intakes.20  The IOM chose results from the in-vitro hydrogen peroxide-induced 
erythrocyte hemolysis test as a marker of vitamin E status because increased peroxide-induced 
erythrocyte hemolysis was correlated with increased erythrocyte fragility in vitamin E-deficient 
individuals.9  The estimated average requirement (EAR) of 12 mg α-tocopherol per day, which is 
expected to result in a serum α-tocopherol concentration of 27.9 µmol/L (12,025 µg/L), was set in 
humans on the basis of vitamin E depletion and repletion studies in men with the use of erythrocyte 
hemolysis as the biomarker.20,86  The recommended daily allowance (RDA) of 15 mg α-tocopherol per 
day was extrapolated from that value.  The following are conversion rates for D-α-tocopherol: 
• 1 mg/dL α-tocopherol = 23.22 µmol/L α-tocopherol 
• 1 IU α-tocopherol = 0.67 mg α-tocopherol (670 µg α-tocopherol) 
• 1 µg/ml α-tocopherol = 2.32 µmol/L α-tocopherol 
According to the IOM, only α-tocopherol meets human vitamin E requirements because it was the 
only isoform that was demonstrated to reverse vitamin E deficiency symptoms in humans, and was the 
only form maintained in plasma and tissues.20  The upper limit of tolerable intakes (UL) is 1000 mg/day, 
equivalent to 1100 IU synthetic or 1500 IU natural vitamin E.20  The UL was based on the adverse effect 
of an increased bleeding tendency observed in rat studies.87   
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Table 1:  Dietary Reference Intakes for Women and Infants20 
 
 
 
The Dietary Reference Intakes for vitamin E as reported by the Institute of Medicine. 
Values are reported in mg/day of vitamin E 
 
In normal, healthy adults who consume a variety of foods, including nuts, seeds, and whole 
grains, plasma α-tocopherol concentrations average ~20 µmol/L, whereas those individuals who consume 
supplements or fortified foods have concentrations that average ~30 µmol/L or more.88  National 
Examination Survey III (NHANES III) data compiled from 1988 to 1994 was used to determine a median 
α-tocopherol intake (including supplements) of 10.3 mg/day α-tocopherol and a median dietary intake 
from food alone of 9.4 mg/day in the United States.20,89  Assessing normal plasma α-tocopherol 
concentrations in children is complicated because α-tocopherol is transported in plasma lipoproteins and 
due to the fact that α-tocopherol increase with age.90  Data from participants of the myocardial case-
control study in Costa Rica showed estimates of mean + SEM vitamin E intakes in adolescents (9.2 + 0.2 
mg α-tocopherol/day) were higher than those of adults (8.4 + 0.2 mg α-tocopherol/day).  However, when 
corrected for cholesterol concentration, plasma α-tocopherol concentrations were significantly lower (P < 
0.05) in adolescents (17 + 0.4 µmol/L, corrected for cholesterol concentration) compared with adults (26 
+ 0.6 µmol/L).  Due to this discrepancy, researchers have proposed other laboratory methods, such as 
urinary α-CEHC, with regard to vitamin E status in humans.   
Vitamin E has been regarded as generally safe when administered orally, even in very high 
doses,91 but toxicity has occurred with parenteral administration and less commonly with high-dose oral 
administration.  Adverse effects of vitamin E in adults include increased bleeding tendency and impaired 
immune function.92   
 
Age Group EAR RDA AI UL 
Infants 0-6 months   4 ND 
Women ≥19 years 12 15  1000 
Pregnant Women ≥19 years 12 15  1000 
Lactation ≥19 years 12 19   1000 
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VITAMIN E DEFICIENCY 
Alpha-tocopherol is considered the most important lipid-soluble antioxidant in cell membranes.93  
It protects cell membranes from lipid peroxidation by breaking the lipid radical chain reaction and acts as 
a direct scavenger of superoxide and the hydroxyl radicals.93  Circulating α-tocopherol concentrations <12 
µmol/L (5168 µg/L) are defined by the IOM to be in the deficient/inadequate range for healthy adults 
with low levels defined as <20 µmol/L (8620.7 µg/L).20  Symptoms of deficiency include a progressive 
neurologic disorder, spinocerebellar ataxia, which occurs as a result of a dying back of peripheral nerves, 
specifically the sensory neurons.94  In humans, severe vitamin E deficiency often occurs due to a genetic 
defects in the α-TTP resulting in the rapid depletion of plasma α-tocopherol and causing ataxia with 
vitamin E deficiency (AVED).95,96  Vitamin E deficiency also occurs with fat malabsorption due to 
genetic defects in the microsomal triglyceride transfer protein, fat-malabsorption syndromes,87 or surgical 
procedures such as gastrectomy or gastric bypass.97-101  
In 2015, McBurney, et al.86 assessed serum concentrations of α-tocopherol in participants with 
data collected from NHANES 2003-2006.  Distributions of serum concentrations for the entire population 
were stratified by consumption of food without supplement use (FOOD) and food and supplement use 
(FOOD+DS).  The mean (+ SEM) of α-tocopherol was 29.6 + 0.2, 33.7 + 0.3 µmol/L for the population > 
20y for FOOD and FOOD+DS use, respectively.  The mean serum α-tocopherol for men > 20y was 25.0 
+ 0.2 and 33.8 + 0.4 μmol/L and for women > 20y was 24.9 + 0.2 and 33.7 + 0.3 μmol/L by FOOD and 
FOOD+DS use, respectively.  Only 0.6% of Americans were clinically deficient, but over 87% of 
individuals between 20-30y had serum α-tocopherol concentrations below 30 µmol/L, whereas 67.9% of 
those 31-50 and 43.1% of those 51+y were below the criterion of adequacy for vitamin E (P < 0.01).   
Insufficiency in men has been associated with impairments in spermatogenesis and sperm 
competiveness.102,103  Epidemiological data has shown that infertile men had a lower α-tocopherol 
concentration in both the sperm (1.48 vs 1.68 µmol/L) and serum (17.8 vs 22.0 µmol/L) compared to 
fertile males.104  Additionally, men with higher dietary and supplement intakes of vitamin E have been 
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shown to have less sperm DNA damage105 and recent studies have reported a positive association between 
vitamin E supplementation and increased sperm count and mobility in mice and humans.106,107   
Deficiency is more frequently found in children, especially newborns, likely because they have 
limited stores and are growing rapidly.9  Vitamin E supplements have been prescribed for children that 
are diagnosed with vitamin E deficiency.  α-tocopherol supplements are recommended because they 
prevent the further progression of the neurologic abnormalities, and in some cases, can reverse them.9   
MATERNAL AND INFANT SERUM VITAMIN E LEVELS 
Maternal Serum Vitamin E Levels 
Vitamin E was first discovered for its role in supporting healthy pregnancy and development.15  
In women, increased production of biomarkers of oxidative stress have been associated with acute 
pregnancy complications or spontaneous abortion.  Prevalence of vitamin E deficiency in pregnancy and 
the effect of maternal deficiency on infants continues to be debated.  Previously, vitamin E deficiency was 
thought to be relatively rare in pregnant women as it was detected in less than 10% of individuals in 
different studies without higher risk for maternal and fetal complications.108-111  However, it is important 
to note that criteria for maternal deficiency is not standardized and may be identified at <16 µmol/L or 
<12µmol/L depending on the study.  A 2014 cohort of HIV-infected mothers in Brazil112 reported a mean 
serum α-tocopherol level of 17.1 + 4.9 µmol/L with only 1 participant (1%) classified as being deficient, 
while a 2015 prospective cohort found 51% of women attending antenatal care in North-West Nigeria 
were clinically deficient in vitamin E (5.99 + 3.95 µg/dL).113  Serum vitamin E in the North-West Nigeria 
subjects significantly decreased with the progression of pregnancy (1st trimester: 10.27 + 5.05; 2nd 
trimester: 5.23 + 3.45; 3rd trimester: 2.49 + 3.35; P = 0.01) with a corresponding increase in the level of 
malondialehyde, (MDA) indicating an increase in oxidative stress.114  Low serum α-tocopherol may be a 
result of physiological hemodilution of pregnancy, inadequate intake, and increased oxidative stress in 
this population.  Conversely, in Saudi Arabia, Al Senaidy et al.115 reported that during pregnancy, α-
tocopherol levels steadily increased, reaching maximum levels at late gestation (first trimester: 16.4 + 1.3 
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µmol/L, third trimester: 19.2 + 1.6 µmol/L, P <0.05), with a corresponding increase in cholesterol and 
triglycerides.  The pronounced increase in the total plasma vitamin E concentration in the late stage of 
normal pregnancy is thought to be due to gestational secondary hyperlipidemia and to the accompanied 
increases in lipoperoxides.  Here, correlation coefficients between vitamin E and plasma total cholesterol, 
triglycerides, and total lipids were 0.76 (P < 0.001), 0.53 (P < 0.05), and 0.62 (P < 0.001), respectively.  
Optimum levels of γ-tocopherol were at mid-gestation (second trimester: 2.1 + 0.2 µmol/L), which was 
significantly higher than that of non-pregnant women (1.8 + 0.2 µmol/l, P <0.05).  The sharp decline that 
continued in the third trimester and after delivery may be explained by the increase in α-tocopherol, 
resulting in the displacement of γ-tocopherol.  Scholl et al.116 found pregnant women at 28 weeks 
gestation with the highest circulating concentrations of α-tocopherol were Asian (Ptrend < 0.0001, 
ANOVA) and older than 16 years of age (>16YO: 11.12 + 0.16 µg/mL; <16YO: 10.22 + 33µg/mL; P for 
trend <0.01, ANOVA).  Obese women (BMI > 29) had significantly lower concentrations of α-tocopherol 
(obese: 10.99 + 0.15 µg/mL; non-obese: 11.51 + 0.09 µg/mL; P < 0.01, t test) and significantly higher 
concentrations of γ-tocopherol (obese: 2.51 + 0.04 µg/mL; non-obese: 1.84 + 0.09 µg/mL; P < 0.0001) 
than did the non-obese women.  Concentrations of both α- and γ-tocopherol isomers increased 
significantly (P < 0.0001) between entry to the study and week 28 gestation (entry α- and γ-tocopherol: 
11.37, 1.92 µg/mL; 28-week gestation α- and γ-tocopherol: 13.70, 2.11 µg/mL).  A prospective case-
control study by Sen, et al.117 studied micronutrient status in lean (BMI 18-25) and obese (BMI > 30) 
pregnant women and found vitamin E levels were significantly (P < 0.05) lower in the obese group than 
the lean group and correlated with maternal BMI (r = -0.19).   
A case-control study of 1605 pregnant Bangladeshi women who participated in a placebo-
controlled supplementation trial assessed odds ratios (ORs) of miscarriages in women with low serum α- 
and γ-tocopherol (<12 μmol/L and <0.81 μmol/L, respectively).  Results showed low α-tocopherol was 
associated with an OR of 1.83 (95% CI: 1.04, 3.20) whereas a low γ-tocopherol concentration was 
associated with an OR of 0.62 (95% CI: 0.41, 0.93) for miscarriage.118  These data suggest low α-
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tocopherol may be associated with an increased risk of miscarriage while low γ-tocopherol is associated 
with a decreased risk.  In 2015, a prospective, cross-sectional study of Turkish women found serum 
vitamin E levels were not significantly different between women with preterm premature rupture of 
membranes (PPROM) and those without (P = 0.15).119   However, it is important note that the cases and 
controls of this trial had much higher levels of vitamin E (20.38 + 6.47 and 18.15 + 6.38 mg/L, 
respectively). 
Impaired antioxidant activity and the reduction of antioxidant levels, which increase the level of 
lipid peroxidation products, may cause peroxidative damage of vascular endothelium and result in clinical 
symptoms of preeclampsia.120  In 1999, Sagol et al.120 found significant higher (P = 0.03) serum α-
tocopherol levels in women with normal pregnancy (7.4 + 2.72 µg/L) versus those with severe pre-
eclampsia (5.6 + 3.8 µg/L).  These results were reflected by Siddiqui et al.,121 who reported preeclampsia 
was associated with significantly lower serum levels of α-tocopherol (pre-eclamptic: 26.1 + 9.15 µmol/L, 
normal: 34.64 + 10.55 µmol/L, P < 0.05).  In a Canadian case control study by Cohen, et al.,122 median 
(IQR) of α-tocopherol was significantly lower in cases of preeclampsia than in controls (P = 0.07) 
without a significant difference found in γ-tocopherol levels (P = 0.60). The adjusted odds ratios (<34 
weeks) for α-tocopherol (0.92; 95% CI: 0.72, 1.17) and α-tocopherol:cholesterol (0.82; 95% CI: 0.65, 
1.04) suggest an inverse association between serum vitamin E and overall preeclampsia risk.  Atiba, et 
al.123 studied plasma MDA and vitamin E levels in the second and third trimesters in pre-eclamptic 
Nigerian women.  As a group, mean plasma vitamin E levels were highest in the non-pregnant subjects 
(30.24 + 14.09 µmol/L) and lowest in subjects with pre-eclampsia (26.9 + 13.81 µmol/L).  In the second 
trimester, mean plasma vitamin E was significantly lower in preeclamptic pregnancy (25.09 + 12.79 
µmol/L) than in comparison with the nonpregnant group (30.24 + 14.09 µmol/L; P < 0.005).  The lower 
value of vitamin E in the second trimester of pre-eclamptic women (25.09 + 12.79 µmol/L) was lower 
than that of normal pregnancy (28.62 + 13.86 µmol/L), but the difference was not considered statistically 
significant (P = 0.068).   
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Maternal body fat accumulation during early pregnancy allows the accumulation of an important 
store of long-chain polyunsaturated fatty acids (PUFAs) derived from the maternal diet and maternal 
metabolism.124  During the first two-thirds of gestation, the maternal body accumulates fat, but stops 
during late gestation because maternal lipid metabolism changes to a catabolic condition.125 At the end of 
gestation, there is an enhanced lipolytic activity in maternal adipose tissue in order to transfer long-chain 
polyunsaturated fatty acids (PUFAs) to the fetus that is at its maximal growth.124  A study by Mino et al. 
showed that the ratio of plasma α-tocopherol concentration to plasma total lipid content remains 
unchanged during gestation, while the red blood cell (RBC) α-tocopherol levels decrease somewhat 
during the last trimester.  RBC tocopherol levels remained unchanged (170-180 µg/100 mL packed cells) 
during the first trimester, but decreased gradually and reached a minimal level (138.4 + 5.3 µg/dl packed 
cells) at 40 weeks.  The difference in the level was significant between the first 15 weeks and 40 weeks (P 
< 0.05).126  The result that RBC tocopherol levels decrease somewhat during the last trimester may 
indicate that decreases in tissue tocopherol result in less tocopherol available for biological function in the 
biomembrane.   
Infant Serum Vitamin E Levels 
Vitamin E is extremely important during the early stages of life, from the time of conception to 
the postnatal development of the infant.  After fertilization, vitamin E has a positive impact on the 
development of early embryos which are susceptible to be damaged by ROS.127   At birth, an adequate 
supply of vitamin E to the newborn is of utmost importance to protect the organism against oxygen 
toxicity and to stimulate the development of its immune system.128,129  Brion et al.13 proposed 24-hour α-
tocopherol levels between 0.5 and 3.5 mg/dL to be both adequate and safe as serum levels > 0.5 mg/dL 
(5004.3 µg/L) are required for protection against lipid peroxidation.  However, as previously discussed, 
vitamin E is affected by total lipids, and therefore some experts advocate that the vitamin E/total lipids 
ratio is more suitable to reflect the true tissue level.130,131  Supplemental dosing of vitamin E has been 
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suggested as a potential agent for the prevention of intracranial hemorrhage due to vitamin E’s function to 
protect cell membranes against lipid peroxidation.132-134   
Factors that may impact serum vitamin E levels of newborns include:  nutrition status of the 
mother, birth order, intrauterine growth, and birth weight.135  The relationship between gestational age 
and vitamin E continues to be debated.  Earlier studies by Wright et al.,136 Leonard et al.108 and Haga et 
al.137 found no significant difference in vitamin E levels between preterm and term babies.  However, in 
the 1999 study by Chan et al.,138 a weak, but significant correlation with gestational age and vitamin E 
(without distinction of tocopherol isoform) was found, (r = 0.13, P = 0.046).  No significant correlation 
was found between vitamin E and birth weight (r = 0.08, P = 0.2).   
Studies in Tunisia and Thailand found the prevalence of low α-tocopherol levels in term 
newborns to be 56% and 77%, respectively, while da Silva Ribeiro et al. found 90% of newborns from a 
study in Brazil.139-141  Wu et al.142 studied serum vitamin E levels in full-term neonates in order to 
establish a reference range and found mean α- and γ-tocopherol levels of 0.212 + 0.127 mg/dL and 0.029 
+ 0.019 mg/dL respectively with a vitamin E/total lipids ratio of 1.219 + 0.740 mg/dL.  Preterm infants 
are born with sparse body fat and low body stores of fat-soluble vitamins, including vitamin E as 
demonstrated by elevated erythrocyte hemolysis in the presence of hydrogen peroxide.143,144  In the study 
by Wu, et al., preterm infants <32 weeks gestation were found to have mean α- and γ-tocopherol levels of 
0.158 + 0.105 mg/dL and 0.019 + 0.015 mg/dL with a vitamin E/total lipids ratio of 0.847 + 0.532 mg/dL.  
Here, the mean value of vitamin E level in preterm neonates was significantly lower than that of full-term 
infants (P = 0.024) but the mean ratio of vitamin E/total lipids did not significantly differ (P = 0.276).142  
Wu et al.142 went on to separate subgroups of infants <32 weeks gestation and >32 weeks gestation and 
concluded that pre-term infants had lower α-tocopherol levels, but not at a level of significance (GA < 32 
wk: 0.158 + 0.105; GA > 32 wk: 0.176 + 0.091, P = 0.604).  The clinical assessment of vitamin E 
deficiency remains a challenge in preterm infants, because serum tocopherol levels may not reflect tissue 
levels and depend on serum lipid levels.145 
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Relationship of Serum Vitamin E Status in Mothers and Infants:   
Pregnancy is a state of increased oxidative stress.  Tocopherols are essential micronutrients that 
can react with ROS such as peroxyl radicals and singlet molecular oxygen, exerting a protective 
antioxidant effect.146  α-TTP seems to play a role at earlier stages of pregnancy and has been identified in 
the secretory epithelium of the human uterine glands as well as in the secondary yolk sac during early 
pregnancy.  Its importance is in supplying vitamin E to the fetus during that period.147  The expression of 
α-TTP was observed in the uterus and its levels transiently increased after implantation, suggesting that 
the placental oxidative stress is protected by vitamin E which is essential for the formation of labyrinthine 
trophoblasts and is likely to play a role in the critical process of implantation.148 
Although vitamin E has been shown to be essential to the fetus during pregnancy, the net 
placental transfer appears to be low and is not, or only slightly influenced by variations in maternal 
vitamin E intake or supplementation.149  Neonatal vitamin E levels have been shown to be only 1/6 to 1/2 
of their mothers and, in general, plasma α-tocopherol concentrations <12 µmol/L are associated with 
increased infection, anemia, stunting of growth, and poor outcomes during pregnancy for both the infant 
and the mother.9,108  Without distinguishing which tocopherol isoform, Martinez et al.150 found serum 
vitamin E levels in mothers, placenta, and newborns to be 1.23 + 0.44 mg/dl, 1.28 + 0.44, and 0.58 + 0.38 
mg/dL respectively.  Again, in a 2014 cohort where only 1% of HIV-infected mothers were vitamin E 
deficient, 81.1% of infants were deficient with a mean serum α-tocopherol level of 8.5 + 3.4 µmol/L.112    
Tocopherols are also significantly higher in maternal plasma than in cord blood (P < 0.001)151  A cross-
sectional study, da Silva Ribeiro et al.141  explored the relationship between maternal α-tocopherol 
concentration levels and the association of α-tocopherol levels of the newborn and colostrum.  Results 
showed the α-tocopherol level in umbilical cord was 20% of that in maternal serum (mean umbilical cord 
blood, CI: 6 mmol/L, 5-8); mean maternal serum α-tocopherol, CI: 28 mmol/L, 24-32; P < 0.001, 
Wilcoxon test). Researchers also found that newborns born to mothers with marginal levels of alpha-
tocopherol at the end of pregnancy also had lower alpha-tocopherol levels (P <0.001), suggesting that 
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maternal vitamin E status during pregnancy protects against low vitamin E levels at birth.141  Different 
mechanisms have been proposed to explain the low transfer of vitamin E to the placenta.  Jauniaux, et 
al.147 proposed the lack of lipids (triglycerides, total cholesterol, and phospholipids) in the circulation of 
fetuses and neonates and its inefficient trans-placental transfer may, among others, contribute to the low 
levels of α- and γ-tocopherol in neonate plasma.  Cholesterol and triglyceride concentrations, which are 
strongly correlated to the levels of α-tocopherol have been found to be lower in cord blood as compared 
to maternal plasma.151 
Although placental transfer of vitamin E is limited, α-TTP appears to play an important role in the 
placental transfer of vitamin E by maintaining adequate α-tocopherol levels in the fetus by facilitating the 
transfer of the hydrophobic nutrients between maternal and fetal circulation.152  According to Kaempf, et 
al.,11 fetal tissue concentrations are gestation-related and “stores” of vitamin E are not accumulated in 
utero.  The placenta may also restrict vitamin E passage to prevent its accumulation by the fetus.  An in 
vitro study by Schenker, et al.153 investigating the transfer of vitamin E across the term, normal human 
placenta, has shown that vitamin E is transferred slowly, at a rate of only 10% of L-glucose.  In contrast 
to the satisfactory level of aqueous-phase defenses, the primary lipid-phase defense, α-tocopherol, only 
crosses the placenta poorly and is presumed to be relatively deficient in the face of oxidative stress in 
neonates after delivery108  
In relation to fetal growth, Scholl et al.116 found a high plasma concentration of α-tocopherol at 28 
weeks gestation was associated with a nearly 3-fold reduction in risk of bearing a small-for-gestational 
age (SGA) infant when highest and lowest quintiles were compared with the P for trend across quintiles 
(P < 0.05).  Additionally, the concentration of α-tocopherol was significantly lower at week 28 when data 
from women who delivered an SGA infant were compared with women who did not deliver an SGA 
infant (SGA infant: 12.95 + 0.35 µg α-tocopherol/mL; no SGA infant: 13.73 + 0.09; P < 0.05, t test).  
These results reflect previous studies of the effects of maternal concentrations of Vitamin E on pregnancy.  
A prospective cohort by Dresfuss, et al.154 reported low vitamin E concentrations (without discrimination 
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of tocopherol isoform) <8.0 mg/L were associated with a higher risk of SGA (Adjusted OR: 1.89; 95% 
CI: 1.10, 3.27) but was not a determinant of low birth weight (LBW).  
Studies conducted on laboratory animals have allowed to show some aspects of the transfer of α-
tocopherol that are impossible to investigate in humans.  In rats, the transfer appears higher in lung and 
heart tissue as compared to liver which was very low, suggesting that there is some preferential 
incorporation into some tissues as compared to others.155  In guinea pigs, which seem to have higher 
placental transfer of α-tocopherol than that reported by other species, it was shown that at late gestation, 
the fetal liver appears to act as a storage site for α-tocopherol, the majority of which are released 
immediately following birth.156,157  In contrast to rats, lung and brain vitamin E levels in guinea pigs are 
relatively constant over the final period of gestation and during early neonatal life.  Levels of α-
tocopherol in the brain and lung appear to be similar to that of RBC, while plasma α-tocopherol content 
varies considerably and does not accurately reflect tissue α-tocopherol status.158  Fetal and maternal lung 
α-tocopherol concentrations in these guinea pigs were similar at all time points during pregnancy, 
whereas fetal liver α-tocopherol status was always considerably greater than maternal liver α-tocopherol 
content.157   
MATERNAL VITAMIN E INTAKE 
Children born to mothers with sub-optimal calorie intake have been shown to have an increased 
risk of neurocognitive disorders.159  Now known as the developmental origins of health and disease 
hypothesis (DOHAD), maternal health and quality of diet may impact fetal development, with long-term 
implications for the child’s future health.160   Brunst, et al.161 analyzed participants from the Programming 
of Intergenerational Stress Mechanisms (PRISM) study, a prospective pregnancy cohort of 276 mother-
child pairs in the United States.  Vitamin E was one of two most common inadequacies identified with 
51.5% of mothers consuming less than the EAR (12 mg/day).  When compared with Caucasians, African 
Americans and Hispanics had greater OR’s of inadequate intakes across all antioxidants and being 
foreign-born was a significant predictor of vitamin E inadequacy (OR = 3.73; 95% CI: 2.04, 6.82).  The 
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OR of inadequacy increased more than twofold among those experiencing difficulty living on their total 
household income or those with difficulty in meeting monthly payments/bills.   
A study by Turner et al.162 found that estimates of vitamin E intake were positively associated 
with maternal plasma α-tocopherol levels.  A prospective cohort of 1231 gravid women from Camden, 
New Jersey found that women consumed 7.19 + 0.13 mg α-TEE per day when adjusted for energy intake.  
Those who consumed vitamin E at the recommended daily allowance had circulating concentrations of α-
tocopherol 0.42 µg/mL higher than a gravid woman with mean vitamin E intake of the sample.  Women 
using prenatal multivitamins daily by week 28 increased circulating concentrations of α-tocopherol by 
0.966 µmol/mL as compared to women who did not use prenatal vitamins (P < 0.0001; 95% CI 0.468-
1.464).  Schulpis, et al.163 studied α-tocopherol levels in the sera in Greek and Albanian mothers. Greek 
mothers had relatively high α-tocopherol levels (32.9 + 9.5 µmol/L) with 0% of infants deficient.  This 
result was thought to be due to the exclusively used vegetable oils and especially olive oil in their 
Mediterranean diet.  In contrast, Albanians, accustomed to using animal fat in their diet, were found to 
have normal levels of serum alpha-tocopherol (20.0 + 8.8 µmol/L), but 8% of their newborns were 
vitamin E deficient (<12.5 µmol/L).163  When examining α-tocopherol/cholesterol in the cord blood, 
Albanian mean α-tocopherol was 14.5 + 2.5 µmol/L with 15% of newborns being deficient (<7.5 
µmol/L). 
Léger et al.164 supplemented ten pregnant women with a daily dose of 1 gram dl-α-tocopherol 
acetate for 3 days before caesarean section with all pregnancies ranging from 37-39 weeks gestation.  The 
vitamin E plasma content of the mothers after supplementation was approximately twice as high as that 
before supplementation (after supplementation: 33.43 + 3.26 mg/L; before supplementation: 18.57 + 2.05 
mg/L; P < 0.01).  Plasma Vitamin E levels of neonates were not increased after short-term 
supplementation (3.51 + 0.38) when compared to cord blood of fetuses at 20-40 weeks of non-
supplemented women from a previous sample.  Researchers concluded that a long period of 
supplementation in mothers is probably needed to increase the fetal vitamin E status.  However, recent 
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animal models have shown supra-nutritional doses of α-tocopherol may lead to long-lasting effects in the 
adult brain, impacting spatial memory.165 
It was suggested that a potential relationship exists between the contents of vitamin E in maternal 
diet and human milk.166 This relationship was originally confirmed by a case report which has 
documented that high maternal intake of vitamin E (approximately 27 mg per day) was reflected by an 
elevated level of the vitamin in human milk.167  A study of breastfeeding mothers from Bangladeshi 
revealed that individuals with extremely low socioeconomic status were characterized by very low breast 
milk levels of vitamin E (2.04 + 0.11 mg/L) which was insufficient to cover requirements of their 
infants.168  However, mean breast milk concentration of α-tocopherol from Bangladeshi women from a 
higher income group of Bangladeshi women did not differ significantly from that of a lower socio-
economic group (higher: 1.86 + 0.08 mg/l, lower: 2.18 + 0.18 mg/l).  It is important to note that the mean 
α-tocopherol of all Bangladeshi women (2.04 mg/L) was lower than the Western values (3-8 mg/L).169  A 
case-control study by Garg et al.170  did not find a significant difference in serum α-tocopherol 
concentrations in colostrum samples from well- and undernourished Indian women (well-nourished 
mothers: 1.272.8 + 890.7 µg/dL; undernourished mothers: 870.2 + 451.2 µg/dl) and a 2013 study by 
Martysiak-Zurowska et al.171 found no significant correlation between dietary vitamin E intake and breast 
milk concentration (r = 0.034, P = 0.22).  Here, dietary intake of vitamin E was determined directly 
before milk sampling based on a 3-day nutritional diary reported by mothers.  Women who took vitamin 
supplements at the time of sampling did not differ significantly from non-supplemented individuals in 
terms of mean breast milk concentration of vitamin E (3.46 + 1.36 TE/mg vs 3.35 + 1.25 TE/mg; 95% CI: 
-0.56, 0.0; P = 0.33).  These results further confirmed findings by Tokusoglu, et al.172 who found no 
relation between maternal vitamin E intake and breast milk concentration.  When mothers were separated 
by socioeconomic groups, participants in both categories in this study had low intakes of corn oil, soy oil 
and fast foods and high intakes of fish, olive oil, sunflower seed oil, nuts, grains, fruits, and vegetables 
based on a food frequency questionnaire. 
24 
 
In a 2015 RCT, a comparison of α-tocopherol concentrations in colostrum at 0 and 24 hours from 
women supplemented with natural and synthetic tocopherol increased colostrum levels by 57.6% and 
39.0%, respectively (P = 0.0000).173  Pires Medeiros, et al.174 evaluated the effect of maternal vitamin E 
supplementation on the α-tocopherol concentrations of colostrum, transitional milk, and mature milk of 
women who had given birth prematurely by providing a single postpartum dose of 400 IU RRR-α-
tocopheryl acetate to women in the experimental group.  Women in the experimental and control group 
had similar baseline concentrations (1159.8 + 292.4 and 1128.3 + 407.2 µg/dL, respectively) with no 
cases of vitamin E deficiency.  Breast milk α-tocopherol increased by 60% 24 hours after 
supplementation in the intervention group and did not increase at all in the control group.  Concentrations 
of α-tocopherol in the transitional milk of the supplemented group was 35% higher compared to the 
control group but no difference was identified in mature milk.  In the study by Barua, et al.,168 
concentration of α-tocopherol varied significantly for the variation of lactation period.  Amongst the 
relatively lower income group, breast milk beyond 6 months post-partum contained a higher 
concentration of α-tocopherol as compared to those of earlier lactation period.  Infants’ calculated daily 
intake of α-tocopherol through breast milk varied from 1.25 mg at 1.5-3 months post-partum to 1.33 mg 
at > 10 months post-partum.   
INFANT VITAMIN E INTAKE 
In newborns with vitamin E deficiency, oxidative stress may cause neonatal diseases.  During 
delivery and right after birth, fetal tissues are exposed to oxidative damage caused by higher free radical 
production because the newborn passes from a low-oxygen to a high-oxygen environment.175  Oxidative 
damage may also be caused by low antioxidant capacity because newborns have a low antioxidant-
enzyme complex.  Ostrea et al.128 found serum concentrations of vitamin E in the term (0.31 + 0.09 
mg/dl) and preterm (0.29 + 0.08 mg/dl) infants are one-third the concentration in the maternal serum 
(0.97 +0.16 mg/dL).  These serum levels can be replenished postnatally through breastfeeding.  Exclusive 
breastfeeding can be a strategy against vitamin E deficiency because the milk excreted until postnatal day 
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4 (colostrum) is particularly rich in α-tocopherol, supplying infants with their vitamin E requirement, 
essential for preventing deficiency.176  Average α-tocopherol content of colostrum ranges from 6.8-23 
mg/L with average γ-tocopherol levels of 1.5 + 0.4 µg/mL and 1.0 + 0.3 µg/mL for early samples.158,169  
Mean concentrations of vitamin E were highest in breast milk of 1 to 3 days, after which their 
concentration rapidly diminished (Table 2).    
Table 2:  Concentrations (mean + SD) of Vitamin E in Human Milk170 
Human Milk Vitamin E (mg/dl) 
Day 1 3.28 + 2.93 
Day 2 2.74 + 2.30 
Day 3 2.09 + 1.44 
Day 4 1.03 + 0.50 
Day 5 0.45 + 0.33 
 
Milk produced during the early weeks postpartum by mothers of preterm infants (preterm milk) 
more closely approximates the nutrition requirements of the preterm infant than does mature human 
milk.177  In 1985, Gross et al.178 reported preterm milk contains approximately two to three times more 
alpha-tocopherol than mature milk.  Yet, the same year, Chappell et al.169 showed the initial α-tocopherol 
content of preterm milk (11 + 2.5 µg/ml) is not significantly different from full term milk (15 + 2.5 
µg/ml).  However, on all subsequent days (7-35), the mean α-tocopherol concentration was significantly 
higher in preterm milk (P <0.05).  Average γ-tocopherol levels for colostrum were 1.5 + 0.4 µg/ml and 
1.0 + µg/ml for early milk.   
Treating preterm infants with pharmacologic doses of Vitamin E (200 mg/day α-tocopherol) has 
been proposed to prevent or limit associated vitamin E deficiency conditions, and current 
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recommendations encourage routine vitamin E supplementation in preterm infants due to decreased 
reserves.13  However, the 2003 Cochrane review on vitamin E supplementation of preterm infants 
concluded that high-dose supplementation, greater than 30 IU/kg/day α-tocopherol, resulting in 
concentrations >3.5 mg/dL (1507 µg/L), was associated with an increased incidence of sepsis (RR 1.57, 
CI 1.15, 2.14; RD 0.06, CI 0.02, 0.11).13  In 2014, Bajčetić, et al.179 conducted an open label study 
involving preterm neonates (control/sepsis) which were divided into two groups non-supplemented and 
supplemented with vitamin E (25 IU/day for 60 days).  At 30 days, vitamin E provoked lower glutathione 
peroxidase (GPx), an enzyme that protects against oxidative damage, compared to untreated septic 
neonates (P = 0.014).  Vitamin E also suppressed glutathione reductase (GR) in septic neonates (P = 
0.025 and P = 0.017 at 30 and 60 days), while causing a significant increase in GPx activity in control 
neonates (P = 0.015 at 60 days).  A meta-analysis by Brion et al.,13 concluded that available data show 
vitamin E supplementation significantly reduced the risk of intraventricular hemorrhage (RR 0.85, CI 
0.73, 0.99) and increased the risk of sepsis after study entry (RR 1.52, CI 1.13, 2.04).  Subgroup analysis 
showed that serum tocopherol levels greater than 3.5 mg/dL in very low birth weight infants were 
associated with a significantly increased risk of sepsis after study entry (RR 1.72, CI 1.24, 2.40), with 
increased risk of necrotizing enterocolitis among those treated for more than one week (RR 1.60, CI 1.02, 
2.52) and with reduced risk for severe retinopathy among those examined (RR 0.34, CI 0.13, 0.88); and 
intravenous, high-dose administration of vitamin E in very low birth weight was associated with a 
significant increased risk of sepsis after study entry (RR 1.56, CI 1.07, 2.27), with increased risk of 
parenchymal hemorrhage in one study and with increased risk of necrotizing enterocolitis among those 
treated for more than one week in another study.  
Bell et al.180 examined the impact of a single enteral dose of α-tocopherol acetate soon after birth 
on serum α- and γ-tocopherol levels of very preterm infants during the first week of life.  Median serum 
α-tocopherol levels in experimental and control groups at baseline were 0.31 mg/dL and 0.33 mg/dL 
respectively. The experimental group received a 50-IU/kg enteral dose of vitamin E as dl-α-tocopherol 
27 
 
acetate within the first 4 hours after birth.  The α-tocopherol levels were similar between the groups at 
baseline but higher in the vitamin E group at 24 hours (median 0.63 mg/dL vs 0.42 mg/dL, P = 0.003) and 
7 days (2.21 mg/dL vs 1.86 mg/dL, P = 0.04) with no differences between groups in γ-tocopherol levels.  
Researchers concluded a higher dose or several doses of vitamin E may be needed to raise serum α-
tocopherol levels and consistently achieve α-tocopherol levels >0.5 mg/dL.  A prospective cohort by 
Kositamongkol, et al.139 studied Vitamin E status in very low birth weight (VLBW) infants at different 
time points in relation to feeding.  At time of birth, median plasma α-tocopherol was 283.7 µg/dL with 
77.4% of the sample identified as having vitamin E deficiency (<500 µg/dL).  Parenteral nutrition with 
multivitamin supplementation was started within 24 to 48 hours of life with enteral feeding initiated as 
soon as clinically stable with an increment of 15 to 25 mL/kg/day.  At the time of full feeding, median 
plasma α-tocopherol was 871 µg/dL with only 16.1% of infants deficient.  Again, this study concluded a 
higher dose of vitamin supplementation may need to be considered, especially for those who are at risk 
for deficiency. 
VITAMIN E CONTENT OF INFANT FEEDING 
In newborn infants, vitamin E from dietary sources prevents vitamin E deficiency.  Elisia et al.58  
found that α-tocopherol was the dominant vitamin E isoform in human milk while γ-tocopherol was 
present at significantly (p<0.05) lower concentrations.  Depending on the stage of lactation, human breast 
milk has been found to have 2.07-12.13 mg α-tocopherol/L and 0.22-0.60 mg/L γ-tocopherol.  Infant 
formulas contained significantly (p<0.05) higher concentrations of γ-tocopherol (5.5 µg/mL-9.6 µg/mL) 
compared to human milk.  Infant milk is a human milk substitute composed of de-fatted bovine milk and 
a blend of vegetable oils.58  The use of vegetable oils as the lipid component of infant formula leads to the 
relatively high amount of γ-tocopherol in formula.171   
A study by Anderson, et al.167 revealed that the average content of vitamin E in the infant 
formulas intended for children under 6 months of age amounts to 4.34 mg (including 3.94 mg of α-
tocopherol) per 1 liter of ready-to-feed solution, with the minimum level of vitamin E in infant formulas 
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being 0.5 mg/100 kcal.  This concentration did not differ significantly from that of human milk from the 
14th day of lactation and was higher than the breast milk concentrations determined on the 30th and 90th 
day of lactation.  In contrast, mean concentrations of γ-tocopherols in analyzed infant formulas were 
approximately 5- to 18-times higher than in human milk.  This disproportion in γ-tocopherol 
concentration results from the technological aspects of infant formula manufacturing.171  During 
processing, components of the formula are exposed to high temperatures and aerobic conditions which 
promote oxidation of PUFAs included in formulas.  γ-tocopherols are added to prevent the oxidative 
degradation and have been shown to promote pro-inflammatory responses in the fetal-derived small 
intestinal cell line.59,181  The potentially distinct vitamin E profile between human milk and infant formula 
could be a contributing factor to the greater susceptibility of formula-fed infants to contract inflammatory 
conditions compared to breast-fed infants.14   
Recommended doses of intravenous multivitamins in VLBW infants vary considerably.   The 
optimal amount of parenteral vitamin E in preterm infants in uncertain, although the maximum 
recommended dose for any neonate is 7 IU per day.13  In 2004 the AAP endorsed a dose of 2.8 IU/kg/day, 
which can be provided either by 2 ml/kg/day of MVI® PediatricTM or by 1.6 ml/kg of Infuvite PediatricTM 
in VLBW infants.182  Intakes of IV vitamin E > 4IU/kg/day often yield potentially toxic serum tocopherol 
levels (>81µmol/L or 3.5 mg/dL) after 2 to 3 weeks of administration.182  Toxic doses of vitamin E 
increase the risk of infection and hemorrhage by at least three mechanisms: decreased leukocyte function, 
a decrease in vitamin K-dependent factors in vitamin K-deficient individuals, and inhibition of platelet 
prostaglandin synthesis and platelet aggregation.182   
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CHAPTER 3: METHODS 
STUDY DESIGN AND POPULATION 
After obtaining University of Nebraska Medical Center Institutional Review Board approval, 
parents of infants admitted to the NICU who meet eligibility criteria were approached by study personnel 
and informed consent was obtained from a parent for each infant enrolled.  Exclusion criteria included: 
infants with congenital abnormalities, inborn errors of metabolism, gastrointestinal, liver, or kidney 
disease, anemia, and those that required blood transfusions.  Infants were also excluded if the parents 
were under 19 years of age or if infants were made wards of the State of Nebraska.   
DATA AND BLOOD COLLECTION 
 Maternal baseline and clinical data was collected and included race, body mass index (BMI), 
delivery mode, birth month, gestational diabetes mellitus, preeclampsia, placental chorioamnionitis, 
serum α- and γ-tocopherol levels, and dietary intake.  Infant baseline and clinical data was collected and 
included sex, gestational age, birth weight and percentile, birth head circumference and percentile, birth 
length and percentile, respiratory distress syndrome (RDS), necrotizing enterocolitis (NEC), 
intraventricular hemorrhage (IVH), positive blood cultures, and cord blood α- and γ-tocopherol levels.  A 
subject was noted to have any of the above conditions if a medical diagnosis was made during the NICU 
stay in the electronic medical record.  
 Thirty-four mother-infant pairs were enrolled into the study.  Maternal and umbilical cord blood 
samples were taken at the time of delivery.  Samples were processed efficiently after collection, protected 
from heat and light, and stored in -80⁰  F freezers until they were analyzed.  Dietary intake throughout 
pregnancy was assessed by administering food frequency questionnaires (FFQ) to the mothers.  The 
FFQ’s encompassed typical intake from supplements, food from all of the major food groups, and 
beverages over the past year.  FFQs were analyzed using the Harvard nutrient-composition database 
which contains food composition values from the United States Department of Agriculture. 
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 Blood samples were collected from participating infants at one time point during the 
administration of each feeding modality (parenteral, breast milk, formula) after the feeding modality has 
been stable for 72 hours.  The half-lives of α- and γ-tocopherol are 48 and 15 hours,20 respectively, 
therefore 72 hours should allow adequate time for serum concentrations to reflect intake.  Infants who are 
receiving parenteral nutrition will have one blood draw after 3 days of parenteral nutrition administration 
(in conjunction with trophic enteral feeding).  As enteral feedings are initiated and advanced, a sample 
will be obtained after the infant has received full feedings of either human breast milk or formula for 72 
hours.  Another sample will be obtained if the infant transitions from breast milk to formula during NICU 
hospitalization and intake is stable for 72 hours.   
 Serum nutrient levels were assessed in the Biomarker Research Institute at Harvard University.  
Concentrations of α- and γ-tocopherol in plasma samples were measured as described by El-Sohemy et 
al.183  Plasma samples (250 µl) are mixed with 250 µl ethanol containing 10 µg/ml rac-Tocopherol 
(Tocol) as an internal standard, extracted with 4 ml hexane, evaporated to dryness under nitrogen, and 
reconstituted in 100 µl ethanol-dioxane (1:1 v/v) and 150 µl acetonitrile.  Samples were quantitated by a 
high-performance liquid chromatography (HPLC) on a Restek Ultra C18 150mm x 4.6mm column, 3 mm 
particle size encased in a column oven (Hitachi L-2350, Hitachi, San Jose, CA) to prevent temperature 
fluctuations, and equipped with a trident guard cartridge system (Restek, Corp. Bellefonte, PA).  A 
mixture of acetonitrile, tetrahydrofuran, methanol, and a 1% ammonium acetate solution (68:22:7:3) is 
used as mobile phase at a flow rate of 1.1 ml/min with a Hitachi L-2130 pump in isocratic mode, a 
Hitachi L-2455 diode array detector (300nm and 445nm), and a Hitachi L-2200 auto-sampler with water-
chilled tray.  The Hitachi System Manager software (D-2000 Elite, Version 3.0) is used for peak 
integration and data acquisition.  Internal quality control is monitored with four control samples analyzed 
within each run.  These samples consist of two identical high-level plasmas and two identical low-level 
plasmas.  Comparison of data from these samples allows within-run and between-run variation estimates.  
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In addition, external quality control is monitored by participation in the standardization program for 
carotenoid analysis from the National Institute of Standards and Technology U.S.A. 
 Ongoing clinical data was collected on all infants during NICU hospitalization.  Infant vitamin E 
intake was calculated based on published infant formula composition and recorded daily.  Sample of 
maternal milk was analyzed for tocopherol content in the Harvard Biomarker Research Institute.  As 
misclassification of serum tocopherol isomers can occur if serum lipid levels are abnormal, all infants at 
risk for hypertriglyceridemia (including those receiving parenteral nutrition) will have monitoring of 
serum lipid levels performed according to clinical protocol.  Otherwise, serum lipid levels will be 
assumed to be normal in an infant population, consistent with other studies of infant serum tocopherol 
levels.180 
STATISTICAL ANALYSIS 
 Descriptive statistics were used for continuous and categorical variables.  Continuous variables 
(maternal BMI, serum α- and γ-tocopherol levels, and dietary intake information and infant gestational 
age, birth weight and percentile, birth head circumference and percentile, birth length and percentile, days 
on ventilator, and serum α- and γ-tocopherol levels) were described using means + standard deviations, 
medians, and ranges.  Ratios of α- to γ-tocopherol levels were also included.  For categorical variables 
(maternal race, delivery mode, birth month, gestational diabetes mellitus, preeclampsia, and placental 
chorioamnionitis and infant sex, supplemental oxygen use, intubation on admission, BPD, RDS, NEC, 
IVH, and positive blood cultures), frequencies and percentages were reported.   
 Spearman correlation coefficients were used to describe associations between maternal and cord 
blood α- and γ-tocopherol levels, maternal dietary intake and maternal and cord blood α- and γ-tocopherol 
levels, gestational age and maternal and cord blood α- and γ-tocopherol levels, and birth weight and 
maternal and cord blood α- and γ-tocopherol levels. 
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Continuous variables, specifically serum γ-tocopherol levels, were compared between the groups 
using a Mann-Whitney test.  Kruskal-Wallis test was used to compare mean ranks of serum α- and γ-
tocopherol levels of infants on different feeding modalities with post-hoc tests performed to examine 
between-group differences. 
 All tests were two-sided and a P-value <0.05 was considered statistically significant.  All 
statistical analysis were carried out using the Statistical Package for the Social Sciences software (IBM 
SPSS Statistics; Version 24.0). 
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CHAPTER 4: RESULTS 
SUBJECT CHARACTERISTICS 
 Maternal and infant demographics and clinical information were obtained for all 34 mother-infant 
pairs.  Characteristics of the study mothers and infants are presented in Tables 3 and 4. 
Maternal Characteristics 
Of mothers enrolled, 64.7% were Caucasian, 17.6% Hispanic, 14.7% African American, and 
2.9% other/unknown race.  Gestational diabetes mellitus, preeclampsia, and placental chorioamnionitis 
occurred in 17.6%, 20.6%, and 11.8% of mothers, respectively.  The mean BMI was 30.7 ± 6.3 kg/m2.  
Vaginal deliveries occurred in 47.1% of the births.  All of the births took place in the summer (29.4% in 
June, 41.2% in July, and 29.4% in August, 2015).   
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Table 3: Maternal Baseline Characteristics 
Categorical Demographics (n=34) n(%)         
Race          
  Caucasian   22 (64.7)      
  Hispanic   6 (17.6)      
  American American  5 (14.7)      
  Other/Unknown  1 (2.9)      
Delivery Mode         
  Vaginal   16 (47.1)      
  Cesarean   18 (52.9)      
Birth Month         
  June   10 (29.4)      
  July   14 (41.2)      
  August   10 (29.4)      
Gestational Diabetes Mellitus  6 (17.6)      
Preeclampsia   7 (20.6)      
Placental Chorioamnionitis  4 (11.8)      
Continuous Demographics (n=34) Mean + SD   Median   Range 
BMI (kg/m2)   30.7 + 6.3  29.62  18.01-41.6 
Serum Vitamin E Levels        
  Alpha-tocopherol (mcg/L) 7910.8 + 5627.0  8326.9  1150.9-23233.9 
  Gamma-tocopherol (mcg/L) 1305.9 + 1178.2  1142.7  63.75-4303.3 
  Delta-tocopherol (mcg/L)  237.9 + 260.4  107.9  0-1019.9 
Dietary Intake (n=20)        
  Calorie Intake (kcals)  2600.3 + 991.3  2323.7  1314.0-4415.59 
  Protein Intake (gm)  104 + 32.3  108.7  44.9-157.4 
  Carbohydrate Intake (gm) 343.1 ± 157.5  299.0  165.6-710.7 
  Fat Intake (gm)  95.1 ± 35.4  89.9  39.0-161.7 
  Alpha-tocopherol (mg) 10.9 + 9.0  9.1  3.67-35.77 
  Beta-tocopherol (mg)  0.4 + 0.3  0.3  0.1-0.79 
  Gamma-tocopherol (mg) 11.2 + 6.0  10.9  4.1-24.1 
  Delta-tocopherol (mg)  2.9 + 1.7  2.7  0.7-6.73 
  Alpha-tocotrienol (mg) 1.1 + 0.7  1.0  0.4-3.7 
  Beta-tocotrienol (mg)  1.0 + 0.6  1.0  0.2-2.1 
  Gamma-tocotrienol (mg) 1.0 + 0.6  1.0  0.2-2.1 
  Delta-tocotrienol (mg) 0.05 + 0.04  0.05  0.0-0.18 
  Total Tocopherol (mg)   33.9 + 17.0   28.4   11.7-65.4 
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Infant Characteristics 
The mean gestational age of infants in the study was 36.7 ± 3.4 weeks and was comprised of 
58.8% males and 41.2% females.  The mean birth weight was 2738.0 ± 835.7 gm (45.5 ± 33.3 %ile), 
mean length was 47.0 ± 4.6 cm (47.2 ± 34.4 %ile), and mean head circumference was 32.3 ± 2.6 cm (45.4 
± 33.5 %ile).  Development of complications after birth in the infants included ROP (2.9%), RDS 
(38.2%), BPD (2.9%), intubation on admission (26.5%), supplemental oxygen use (41.2%), and a positive 
blood culture result (2.9%).  Nine subjects were on a ventilator for an average of 2.0 ± 2.3 days 
throughout their NICU stay.   
Table 4: Infant Baseline Characteristics 
Categorical Demographics (n=34) n(%)         
Sex          
  Male   20 (58.8)      
  Female   14 (41.2)      
Retinopathy of Prematurity (ROP) 1 (2.9)      
Supplemental Oxygen Use  14 (41.2)      
Intubation on Admission  9 (26.5)      
Bronchopulmonary Dysplasia (BPD) 1 (2.9)      
Respiratory Distress Syndrome (RDS) 13 (38.2)      
Necrotizing Enterocolitis (NEC)  0 (0.0)      
Intraventricular Hemorrhage (IVH) 0 (0.0)      
Positive Blood Culture  1 (2.9)      
Continuous Demographics (n=34) Mean + SD   Median   Range 
Gestational Age (weeks)  36.7 + 3.4  37.1  30.3-42.0 
Birth Weight (gm)   
2738.0 + 
835.7  2850.0  840.0-4109.0 
Birth Weight Percentile  45.5 + 33.3  43.4  0.0-98.8 
Birth Head Circumference (cm)  32.3 + 2.6  32.7  25.0-37.0 
Birth Head Circumference Percentile 45.4 + 33.5  43.3  0.0-99.6 
Birth Length (cm)   47.0 + 34.4  47.0  35.0-55.0 
Birth Length Percentile  47.2 + 34.4  48.5  0.0-99.7 
Days of Ventilator (n=9)  2.0 + 2.3  1.0  1.0-8.0 
Cord Blood Vitamin E Levels (n=32)       
  Alpha-tocopherol (mcg/L) 
6093.6 + 
5218.2  3959.1  
1030.1-
19478.3 
  Gamma-tocopherol (mcg/L) 758.8 + 732.1  552.3  103.2-2873.0 
  Delta-tocopherol (mcg/L) 203.7 + 179.8   140.9   22.5-699.2 
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VITAMIN E STATUS 
Maternal and cord blood samples were collected and analyzed for 31 mothers and 32 infants.  
Maternal and cord blood α-, γ, and δ-tocopherol serum levels are displayed in Tables 3 and 4.   
Maternal Status 
 The mean serum α-, γ-, and δ-tocopherols in µg/L were 7910.8 + 5627.0, 1305.9 + 1178.2, and 
237.9 + 260.4, respectively.  The ratio of mean α- to γ-tocopherol was 7910.8:1305.9 or 6.1.  Of the 31 
maternal blood samples, 25.8% had serum levels of α-tocopherol greater than 12015.5 µg/L (27.9 
µmol/L), which is the serum level expected to result from an intake of 12 mg α-tocopherol/day.  45.2% of 
samples had adequate α-tocopherol concentrations >20 µmol/L.  Low α-tocopherol concentration, < 20 
µmol/L (8620.7 µg/L) and >12 µmol/L, was present in 12.9% of maternal samples (Table 5).  41.9% of 
mothers were considered α-tocopherol deficient with serum levels <12 µmol/L (5172.0 µg/L).  
Infant Status 
 At birth, mean serum α-tocopherol levels were 6093.6 + 5218 µg/L (14.1 + 12.1 µmol/L).  20 
infants, or 64.5% of the sample, were considered to be deficient with serum α-tocopherol levels <5000 
µg/L. 12 infants (38.7%) had adequate serum α-tocopherol levels with 0% of infants with a serum level 
>3.5 mg/dL (Table 5).  Mean serum γ-tocopherol at birth was 758 + 732.1 µg/L (1.8 + 1.7 µmol/L).  No 
significant correlations were found between gestational age and infant serum α-tocopherol (r = -0.024, P 
= 0.898) or birth weight and infant serum α-tocopherol (r = 0.005, P = 0.977).  As shown in Figure 5, 
correlation between corrected gestational age and infant γ-tocopherol show a slightly higher correlation 
but remain insignificant (r = -0.312, P = 0.82).  No significant correlation was found between birth weight 
and infant serum γ-tocopherol (r = -0.230, P = 0.205). 
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Table 5: Prevalence of α-Tocopherol deficiency in Mothers and Infants at Birth 
Mothers (n=31) n (%) 
Deficient (<12 µmol/L [<5172.0 µg/L]) 13 (41.9) 
Low (12 - 20 µmol/L [5172.0-8620.7 µg/L]) 4 (12.9) 
Healthy (>20 µmol/L [>8620.7 µg/L]) 14 (45.2) 
    
Infants (n=32)   
Deficient (<0.5 mg/dL [<5004.3 µg/L]) 20 (64.5) 
Adequate (0.5 - 3.5 mg/dL [5004.3-35,196.0 µg/L) 12 (38.7) 
High (>3.5 mg/dL [>35,196.0]) 0 (0.0) 
 
Figure 5: Relationship of Birth Corrected Gestational Age and Infant Serum γ-Tocopherol 
Concentrations 
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Relationship between Serum Vitamin E Levels of Mothers and Infants:  
 Associations between maternal and cord blood tocopherols were determined and are displayed in 
Table 6.  Maternal serum α-tocopherol had a low correlation to infant serum α-tocopherol concentrations 
(r = 0.024, P = 0.899).  Maternal serum γ-tocopherol also has a low correlation to infant serum γ-
tocopherol concentrations, but appears to have a stronger correlation than does maternal and infant α-
tocopherol concentrations. Figures 6 and 7 display correlations of maternal and cord blood α- and γ- 
tocopherol. 
Table 6: Correlations of Maternal and Infant α- and γ-Tocopherol Levels 
  Correlation Coefficient (r) P-Value 
Alpha-Tocopherol 0.024 0.899 
Gamma-Tocopherol -0.204 0.271 
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Figure 6: Relationship of Maternal and Infant Serum α-Tocopherol Levels 
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Figure 7: Relationship of Maternal and Infant Serum γ-Tocopherol Concentrations 
 
There was no significant correlation between gestational age and maternal serum α-tocopherol (r 
= 0.17, P = 0.360) or γ-tocopherol (r = 0.263, P = 0.152). A positive significant correlation was found 
between birth weight and maternal serum γ-tocopherol (r = 0.374, P = 0.038), as shown in Figure 8.  This 
correlation was not observed between birth weight and maternal serum α-tocopherol (r = 0.201, P = 
0.278).  
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Figure 8: Relationship of Birth Weight and Maternal Serum γ-Tocopherol Concentrations 
 
MATERNAL VITAMIN E INTAKE 
FFQs were completed for 21 mothers, but data from 20 FFQs were used for analysis (Table 3).  
FFQ data from one mother was excluded due to results of very high calorie intake (31727 calories), 
exceeding the expected amount.   The median daily calorie intake was 2323.7 + 991.3 calories per day the 
median protein, fat, and carbohydrate intake being 108.7 + 32.3, 89.9 + 35.4, and 299.0 + 157.5 grams per 
day respectively.  Median α- and γ-tocopherol intake without supplementation was 9.1 + 7.8 and 10.9 + 
5.9 mg per day, respectively.   
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Maternal α- and γ-tocopherol intake was not associated with maternal serum α- and γ-tocopherol 
levels (Table 7) or cord blood α- and γ-tocopherol levels (Table 8).  Additionally, no significant 
correlations were found when comparing calorie or fat intake with maternal or cord blood α- and γ-
tocopherol levels as seen in Tables 7 and 8.  Correlations of maternal intake and maternal serum levels 
and maternal breast milk samples were also evaluated without any significant results (Tables 9 and 10).  
However, when maternal intake was separated into groups of meeting the EAR (12 mg/day or over), 
median α- γ-tocopherol concentrations in mothers’ breast milk were significantly correlated (Table 11). In 
the subgroup, median α- and γ-tocopherol levels of mothers meeting the EAR were 9578.0 and 1790.4 
μg/L, respectively, while those not meeting the EAR had levels of 2789.9 and 378.8 μg/L, respectively. 
Table 7:  Correlations of Maternal Intake and Maternal Serum Levels 
Dietary Intake vs Serum Level   
Correlation 
Coefficient 
P-Value 
total calories (kcal) vs α-tocopherol (µg/L) 0.023 0.944 
total calories (kcal) vs γ-tocopherol (µg/L) 0.404 0.192 
total fat (g) vs α-tocopherol (µg/L) 0.412 0.183 
total fat (g) vs γ-tocopherol (µg/L) 0.022 0.946 
α-tocopherol (µg) vs α-tocopherol (µg/L) -0.455 0.137 
α-tocopherol (µg) vs γ-tocopherol (µg/L) 0.078 0.809 
γ-tocopherol (µg) vs α-tocopherol (µg/L) 0.068 0.834 
γ-tocopherol (µg) vs γ-tocopherol (µg/L) 0.49 0.106 
 
Table 8:  Correlations of Maternal Intake and Cord Blood Levels 
Dietary Intake vs Serum Level   
Correlation 
Coefficient 
P-Value 
total calories (kcal) vs α-tocopherol (µg/L) 0.424 0.07 
total calories (kcal) vs γ-tocopherol (µg/L) -0.23 0.926 
total fat (g) vs α-tocopherol (µg/L) 0.402 0.088 
total fat (g) vs γ-tocopherol (µg/L) -0.05 0.838 
α-tocopherol (µg) vs α-tocopherol (µg/L) 0.022 0.928 
α-tocopherol (µg) vs γ-tocopherol (µg/L) 0.07 0.775 
γ-tocopherol (µg) vs α-tocopherol (µg/L) 0.372 0.117 
γ-tocopherol (µg) vs γ-tocopherol (µg/L) 0.049 0.843 
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Table 9:  Correlations of Maternal Serum Levels and Mothers Breast Milk Samples 
Maternal Serum Level vs Breast Milk Samples 
Correlation 
Coefficient 
P-Value 
α-tocopherol (µg/L) vs α-tocopherol (µg/L) 0.199 0.534 
α-tocopherol (µg/L) vs γ-tocopherol (µg/L) 0.244 0.446 
γ-tocopherol (µg/L) vs α-tocopherol (µg/L) 0.246 0.44 
γ-tocopherol (µg/L) vs γ-tocopherol (µg/L) 0.138 0.668 
 
Table 10:  Correlations of Maternal Dietary Intake and Breast Milk Samples 
Dietary Intake vs Breast Milk Samples 
Correlation 
Coefficient 
P-Value 
α-tocopherol (µg) vs α-tocopherol (µg/L) -0.455 0.137 
α-tocopherol (µg) vs γ-tocopherol (µg/L) 0.078 0.809 
γ-tocopherol (µg) vs α-tocoperhol (µg/L) 0.068 0.834 
γ-tocopherol (µg) vs γ-tocopherol (µg/L) 0.49 0.106 
 
Table 11: Correlations of Maternal Dietary Intake and Breast Milk Samples meeting EAR 
(n=6) 
Dietary Intake (>12 mg/day) vs MBM and Cord Blood 
Correlation 
Coefficient 
P-Value 
α-tocopherol (mg) vs MBM α-tocopherol -0.880 0.021 
α-tocopherol (mg) vs MBM γ-tocopherol -0.857 0.029 
α-tocopherol (mg) vs CBM α-tocopherol -0.052 0.494 
α-tocopherol (mg) vs CBM γ-tocopherol -0.515 0.296 
 
Table 12: Correlations of Maternal Dietary Intake and Breast Milk Samples not meeting 
EAR 
Dietary Intake (<12 mg/day) vs MBM and Cord Blood 
Correlation 
Coefficient 
P-Value 
α-tocopherol (mg) vs MBM α-tocopherol -0.279 0.380 
α-tocopherol (mg) vs MBM γ-tocopherol -0.273 0.390 
α-tocopherol (mg) vs CBM α-tocopherol -0.246 0.419 
α-tocopherol (mg) vs CBM γ-tocopherol -0.062 0.841 
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INFANT VITAMIN E INTAKE 
 Table 13 shows serum α- and γ-tocopherol levels after an infant had been stable on a feeding 
modality for 72 hours.  Median α- and γ-tocopherol concentrations in 12 samples of mothers’ breast milk 
were 8215.8 + 4883.2 and 840.5 + 458.8 μg/L, respectively.  Samples of infants stable on breastmilk, infant 
formula, and mixed feeding modalities resulted in median α- and γ-tocopherol levels of 2853.4 and 370.6 
µg/L, 10670.1 and 1107.8 µg/L, and 11185.3 and 1203.0 µg/L respectively.  No infants were stable on only 
total parenteral nutrition for 72 hours; therefore, no data are available.  No significant difference was found 
between groups (α-tocopherol chi-square: 2.653, P=0.27; γ-tocopherol chi-square: 1.962, P=0.375).   
Table 13: Median serum α- and γ-tocopherol levels after 3 days on feeding modality 
  α-Tocopherol (µg/L) γ-tocopherol (µg/L) Ratio (α/γ) 
Breastmilk (n=13) 2853.4 370.6 7.7 
Formula (n=7) 10670.1 1107.8 9.6 
Mixed (n=17) 11185.3 1203.0 9.3 
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CHAPTER 5: DISCUSSION 
VITAMIN E STATUS IN MOTHERS AND INFANTS 
 Circulating α-tocopherol concentrations <20 µmol/L (8620.7 µg/L) were defined by the IOM to 
be in the low range for healthy adults and concentrations <12 µmol/L (5172 µg/L) considered deficient.20  
We found a mean serum α-tocopherol concentration of 7910.8 + 5627.0 with 4% of the sample having 
low serum concentrations and 41.9% of the sample with levels defined as deficient.  While prevalence of 
α-tocopherol deficiency during pregnancy continues to be debated world-wide, it is concerning that a high 
percentage of the sample had mean levels of α-tocopherol are considered low (12.9%) or deficient 
(41.9%) in a predominantly Caucasian sample in an urban setting of a developed country.  Maternal mean 
γ-tocopherol was 1305.9 + 1178.2 µg/L with an α-tocopherol to γ-tocopherol ratio of 6.1.  γ-tocopherol 
levels were similar to those reported by Wu, et al.142 who found a mean maternal γ-tocopherol to be 0.214 
+ 0.122 mg/dL with an α-tocopherol to γ-tocopherol ratio of 5.4.   
Mean cord blood α- and γ-tocopherol levels were 6093.6 + 5218.2 µg/L and 758.8 + 732.1 µg/L 
respectively with 64.5% of the sample having serum α-tocopherol levels <0.5 mg/dL (5004.3 µg/L), 
qualifying as deficient.  Wu et al.142 found 32 of 34 (94.1%) full-term infants had α-tocopherol levels less 
than 0.5 mg/dL with a mean α-tocopherol level at birth of 0.212 + 0.127 mg/dL (2121.8 + 1271 µg/L).  In 
the same study, preterm infants (GA >32 wk) had mean serum α-tocopherol levels of 0.176 + 0.091 
mg/dL (1761.5 + 910.8 µg/L).   
As discussed previously, the exact mechanism of placental vitamin E transfer remains unknown 
and neonatal vitamin E levels are generally only 1/6 to 1/2 those of their mothers.108,150  Conversely, our 
data show neonatal α-tocopherol levels, when comparing cord blood to maternal serum levels, to be 77% 
while neonatal γ-tocopherol was approximately 1/2 that of maternal serum at 58%.  However, when 
comparing medians of maternal serum and cord blood α- and γ-tocopherol, percentages drop to 47.5% 
and 48.3% respectively.  As expected, all correlation coefficients showed no significant association 
between mother and infant plasma levels.  However, these levels were not adjusted for total lipids. 
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In our study, we did not find a significant correlation between gestational age and serum α-
tocopherol levels as opposed to other findings from Chang and Wu.138,142 who found weak, but significant 
correlations.  In agreeance with Chan et al.,138 a lack of association was seen between maternal weight 
and α-tocopherol, but a significant association was seen between maternal weight and γ-tocopherol.   
 
MATERNAL VITAMIN E INTAKE 
 Median maternal α-tocopherol intake without supplementation was 9.1 + 7.8 mg/day.  This value 
is less than the EAR (12 mg/day) and RDA (19 mg/day) for pregnant women.  Our sample had higher 
intakes of vitamin E than Scholl, et al.116 found in women in Camden, NJ (7.19 + 0.13 mg α-tocopherol 
per day) but less than Chappell, et al.169 found in Ontario, Canada (15.0 + 6 mg/day).  Low levels of α-
tocopherol intake in the United States may be explained, in part, by the increased intake of γ-tocopherol, 
which is the predominant isoform of vitamin E in soy oil and processed foods.  Median intakes of α-
tocopherol less than the EAR is concerning due to association between maternal concentration and fetal 
growth and the potential relationship of maternal intake and level of α-tocopherol in human milk.  
Breastmilk can increase oxidative stress index to newborns if serum vitamin E levels are low.184  
Therefore, it is critical for women to have adequate α-tocopherol levels in breast milk to protect infants 
from deficiency and the effects of low antioxidant capacity. 
 Median α- and γ-tocopherol levels from a sample of mothers’ breast milk samples were 8216.9 + 
4883.2 µg/L and 840.4 + 458.8 µg/L, respectively.  These values were lower than that reported by 
Chappell et al.169  in preterm mothers’ breast milk (α-tocopherol: 11 + 2.5 µg/ml; γ-tocopherol: 1.5 + 0.4 
µg/L).  Median α-tocopherol levels in colostrum were also lower than reported by da Silva, et al.141 
(16810 µg/L) but were consistent with reported Western levels (3-8 mg/L). However, when only 
sampling women who had met the EAR for v α-tocopherol in the FFQ, median α, and γ-tocopherol levels 
increase to 9578.0 and 1790.4 μg/L, respectively.   
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IMPROVING VITAMIN E STATUS  
Adequate vitamin E intake is required in infants to prevent vitamin E deficiency, which is 
characterized by hemolytic anemia, edema, thrombocytosis, and rarely spinocerellar degeneration.12  Prior 
to our study, multiple studies have shown pre-term and term infants to be clinically deficient in α-
tocopherol at birth.  Exclusive breastfeeding can be a strategy against vitamin E deficiency as studies 
have shown milk excreted until postnatal day 4 (colostrum) is particularly rich in α-tocopherol, supplying 
infants with their vitamin E requirement, essential for preventing deficiency.176   
In our study, 64.5% of the infant population had deficient serum levels of vitamin E.  
Interestingly, median serum levels of α-tocopherol did not rise above 0.5 mg/dL after 3 days stable on 
infant feeds with only breast milk.  However, both infant formula and mixed modality feeds reached that 
level.  Multiple explanations could be offered to explain the result such as increased nutrient provision 
and vitamin E supplementation in formula and mixed modality feeds.  Of note, with 3 days stable on 
breastmilk, mean serum γ-tocopherol was found to be 370.6 µg/L while mean levels of infants stable on 
formula or mixed modality feeds were 1107.8 and 1203.0 µg/L respectively.  Further research regarding 
the effect of serum levels of γ-tocopherol on inflammation are needed to evaluate indications of use in the 
NICU.  Additionally, further research is needed to re-evaluate the recommended dose of supplemental 
vitamin E for infants on breastmilk alone as a feeding modality to achieve serum levels above 0.5 mg/dL.     
Based on the available evidence from a systematic review, the vitamin E dose recommended by 
the American Society for Clinical Nutrition (2.8-3.5 IU/kg/day) should remain the current standard, 
However, researchers have concluded that the current “best” pharmacologic dose of vitamin E 
supplementation is unclear.182  Bell et al.180 examined a single enteral dose of α-tocopherol while 
Kositamongkol et al.139 studied infants with parenteral nutrition with multivitamin supplementation 
started within 24-48 hours of life with enteral feeding initiated as soon as clinically stable.  Both studies 
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concluded a higher dose of α-tocopherol supplementation may need to be considered, especially for those 
who are at risk for deficiency.   
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LIMITATIONS 
There are limitations to this study that should be taken into consideration.  The overall sample 
size of 34 mother-infant pairs was relatively small and a larger sample size would have been beneficial 
for analysis.   Of the 34 mother-infant pairs enrolled, serum samples from three mothers and cord blood 
samples from two infants were not collected.  Also, this study looked at subjects in the NICU, who are 
often under higher levels of stress due to an increase in health complications.  These results may not be 
consistent with healthy mother-infant pairs at birth.  In addition, it has been proposed that the best 
indicator of vitamin E status is the ratio of tocopherol to circulating lipids.131  This study did not adjust for 
lipids, which may have produced slightly different results. 
21 of 34 mothers completed FFQ with only 20 analyzed.  Almost half of the mothers did not 
complete a FFQ, making it difficult to draw solid conclusions related to the intake of vitamin E intake of 
the population.  As with other intake assessment forms, self-reporting can lead to both under or 
overestimations of intake.   
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CHAPTER 6: CONCLUSION 
This is one of the first studies to evaluate the effect of feeding modality on infant serum α- and γ-
tocopherol levels.  Previously, studies have studied the effect of colostrum and maternal breast milk on 
infant vitamin E tocopherols with a main focus on serum α-tocopherol levels post-partum and the 
difference between pre-term and term infant levels.  This prospective study found results consistent with 
previous research as maternal serum levels, maternal intake, gestational age, and birth weight were not 
significantly correlated with infant serum α- and γ-tocopherol levels.  Additionally, prevalence of vitamin 
E deficiency was high in mothers and infants which is concerning due to the detrimental side effects of 
low levels.  Further research is needed to detect the mechanism of transport of serum tocopherols to the 
fetus and to determine safe supplementation dosages of infants at risk of vitamin E deficiency.    
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